Beauty (Cosmetics)
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Regulation/Legislation Explore this Topic
Latest From Beauty & Regulation
Cosmetics Industry’s Preservatives Crisis Grows More Dire Under New Washington State Law
Washington State Governor Jay Inslee signed into law HB 1047 on 15 May, implementing the most aggressive cosmetics ingredient ban in the country. The Personal Care Products Council and Independent Beauty Association are concerned about a lack of alternative preservatives to replace targeted formaldehyde-releasing substances effectively and affordably and the law’s inconsistency with FDA over lead levels, among other impacts.
House Appropriations Subcommittee Proposes FDA FY2024 Budget $662M Short Of Request
Appropriations Agriculture, Rural Development, FDA and Related Agencies Subcommittee marked up its FY2024 bill on 18 May, proposing $6.579bn for FDA. Total is up from current budget of $6.562bn, but Biden administration proposed $7.2bn for FY2024.
Lauder In-House Counsel: Start Planning For Supply Chain Quality Agreements Under MoCRA
Companies that have struggled to secure quality agreements with suppliers have additional leverage and a new starting point for those discussions, namely the Modernization of Cosmetic Regulations Act. Anand Natarajan, associate counsel at The Estee Lauder Companies, provided his view in a recent FDLI webinar.
Latest From Beauty & Legislation
House Appropriations Subcommittee Proposes FDA FY2024 Budget $662M Short Of Request
Appropriations Agriculture, Rural Development, FDA and Related Agencies Subcommittee marked up its FY2024 bill on 18 May, proposing $6.579bn for FDA. Total is up from current budget of $6.562bn, but Biden administration proposed $7.2bn for FY2024.
Washington State’s Toxic-Free Cosmetics Act, More Aggressive Than California’s, Awaits Governor’s Signature
The specter of reformulations, market disruptions and potential litigation hangs over Washington state as HB 1047 sits on Governor Jay Inslee’s desk. The Toxic-Free Cosmetics Act, seen by industry stakeholders as a metastasized version of California’s legislation of the same name, would ban the sale of cosmetics containing formaldehyde releasers or trace lead above 1 ppm, in addition to PFAS, ortho-phthalates and other ingredients.
US Q1 Consumer Health Earnings Preview: Lifted By Welcome Changes, Or Slowed By Surprises?
An end to US COVID-19 PHE on 10 April doesn’t end inflationary pressure on prices for consumer packaged goods. OTC, supplements and personal care product firms could be reporting consumers during Q1 were going along with price increases, opting for less expensive options or buying less.
Latest From Beauty & Legal Issues
US FTC Pushed For Environmental Reg Harmonization, Organic Definition – ‘Green Guides’ Comments
Cosmetics industry stakeholders agree the US Federal Trade Commission’s “Green Guides” are ripe for an update. Issues old and new need to be addressed and state-level laws and regulations taken into account along with national and international programs and standards, say leading companies, trade associations, and consumer advocacy groups in comments to the agency.
Companies Targeted By FTC Using Penalty Offense Authority Have Strong Defense, Attorney Says
John Villafranco, partner at Kelly Drye & Warren LLP, says the US FTC’s ability to obtain monetary relief using the penalty offense mechanism is questionable both on statutory and Constitutional grounds. Marketers faced with civil penalties – for example, for alleged inadequately substantiated health claims – should stand their ground, he suggests in a recent interview.
L’Oreal Must Stop Selling Harmful Hair Relaxers, Women’s Group Says As Lawsuits Stack Up
Level Up, fighting for gender justice in the UK, says L’Oreal should reformulate or remove its hair relaxers from the market based on a US National Institutes of Health study indicating that frequent, long-term use of such products more than doubles risk of developing uterine cancer. Meanwhile the beauty giant is embroiled in numerous related lawsuits in federal courts around the US.
Business Explore this Topic
Latest From Beauty & Deals
Perfect Corp. Highlights Results Of AR-Based Nail Color Sampling At Sally Hansen
Sally Hansen has seen a 300% increase in shades viewed on its website, and a 120% increase in intent to buy, since it introduced Perfect Corp.’s AR-based virtual try-on tool, the beauty tech firm says. French nail-color specialist Manicurist is the latest to partner with Perfect for its Green Flash brand.
J&J Has Kenvue IPO Roadshow In One Lane, Potentially Long Road For Talc Litigation In Other
Roadshow stated for IPO planned for before end of 2023 of 151.2m shares of Kenvue common stock currently expected at between $20 and $23 per share. Analysts positive on IPO but caution launch wouldn’t come problem-free.
Bayer Trims Consumer Portfolio Selling Solarcaine, Other US, Canada Skin Care Brands To WellSpring
WellSpring, owned by private equity firm Avista Capital Partners, purchasing Solarcaine, diaper rash and skin protectant A+D and Canadian brands Cortate and Complex 15. Bayer’s long-term commitment to consumer health one of key issues facing its next CEO, Bill Anderson.
Latest From Beauty & Business Strategies
Homeopathics, Supplements, OTC Medicines Overlap In Pharmacists’ ‘Over-The-Counter’ Survey
Results of U.S. News & World Report’s first “Best OTC Medicine & Health Products” survey include homeopathic formulations, supplements and non-drug topicals in same categories of indications with nonprescription pharmaceuticals.
Perfect Corp. Highlights Results Of AR-Based Nail Color Sampling At Sally Hansen
Sally Hansen has seen a 300% increase in shades viewed on its website, and a 120% increase in intent to buy, since it introduced Perfect Corp.’s AR-based virtual try-on tool, the beauty tech firm says. French nail-color specialist Manicurist is the latest to partner with Perfect for its Green Flash brand.
Amyris Moving 30 Molecules Through R&D Pipeline, Streamlining Consumer Portfolio
Amyris, Inc. is developing 30 molecules using its bio-fermentation technology, negotiating a bio-manufacturing joint venture that could yield $50m-$100m in proceeds, and simplifying its Consumer portfolio to unlock value. Cost containment and liquidity will continue to be key priorities for the synthetic biotech firm while it targets up to 100% revenue growth in fiscal 2023.
Latest From Beauty & Sales & Earnings
Ulta Working To Combat Surging Retail Theft As Q1 Sales Rise 12.3%
Ulta Beauty says consumers are being more selective in their spending but show “continued willingness to splurge and treat themselves.” The company is implementing additional mitigation strategies in its stores – including placing fragrances in locked cabinets – to combat organized retail theft that is expected to slightly reduce its operating margins for the full year.
Amyris Moving 30 Molecules Through R&D Pipeline, Streamlining Consumer Portfolio
Amyris, Inc. is developing 30 molecules using its bio-fermentation technology, negotiating a bio-manufacturing joint venture that could yield $50m-$100m in proceeds, and simplifying its Consumer portfolio to unlock value. Cost containment and liquidity will continue to be key priorities for the synthetic biotech firm while it targets up to 100% revenue growth in fiscal 2023.
Coty Touts ‘Huge Potential’ In China With Lancaster Skin Care, Rising Fragrance Opportunity
New York-based beauty giant says its strategic bet on skin care in China is starting to pay off with strong consumer response to the recent launch of Lancaster Ligne Princiere. Meanwhile, the firm is ready to deploy its prestige fragrance brands strategically in the country as consumers gravitate increasingly to high-end perfumes.
Marketing Explore this Topic
Latest From Beauty & Launches
Cosmetic And Personal Care Weekly Trademarks Review: 30 May
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Cosmetic And Personal Care Weekly Trademarks Review: 23 May
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Coty’s ‘Most Ambitious Fragrance Project To Date’; Head & Shoulders BARE; Cosmetic Launch News
Infiniment Coty Paris, launching globally in 2024, will “be to fragrance what [ultra-premium] Orveda is to skin care,” the company says. P&G touts Head & Shoulders BARE as the first anti-dandruff shampoo with only nine ingredients. More cosmetic launch news.
Latest From Beauty & Cosmetic Ingredients
EWG’s 2023 Sunscreen Guide: Oxybenzone Use Down, ‘EWG Verified’ Products Up
The Environmental Working Group’s annual sunscreen report finds that one in four products evaluated meet its standards for protection and ingredient avoidance, fairly consistent with the past three years but still worse than 2019. This year, “gold standard” sunscreen products bear the nonprofit’s “Verified” mark.
Cosmetic And Personal Care Weekly Trademarks Review: 30 May
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Cosmetic And Personal Care Weekly Trademarks Review: 23 May
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Latest From Beauty & Ad Complaints
Nutrafol Hair Growth Ads Trigger TINA.org Complaint To Federal Agencies
Ad watchdog group Truth in Advertising, Inc. filed a complaint with the US FDA and FTC over Nutrafol hair growth supplement representations that the organization says are unapproved drug claims and/or don’t meet FTC standards for adequate substantiation, as well as alleged deceptive negative option practices.
FTC Reminds Advertisers Large And Small: Substantiate Health Claims Or Face Civil Penalties
Agency sends flares across wide field of advertisers illuminating the need for marketers to substantiate health claims. Reminder made brighter noting penalties of up to $50,120 per violation.
Does FTC Health Ads Guide Read Like Rulemaking, Ignore Court Decisions On Requiring RCTs?
“I'm not sure they shouldn’t have done a notice of proposed rulemaking,” says attorney Claudia Lewis. From previous guidance, “the FTC has taken it a step in the different direction that you need robust scientific evidence, in their mind robust scientific evidence means clinical data.”
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.